Table 1.
Women (N = 3374) | Men (N = 2243) | ||
---|---|---|---|
% | % | pd | |
Centre | |||
Bordeaux | 23.8 | 23.1 | |
Dijon | 57.4 | 53.7 | |
Montpellier | 18.8 | 23.3 | 0.0002 |
Age (years) (median, IQR) | 73.2 (69.4–77.2) | 72.5 (69.2–76.9) | 0.004 |
Education (>5 years) | 75.3 | 78.6 | 0.005 |
Living alone | 48.2 | 13.9 | <0.0001 |
Smoking | |||
Never | 81.9 | 31.3 | |
Former | 14.4 | 60.6 | |
Current | 3.7 | 8.1 | <0.0001 |
Alcohol consumption (g/day) (median, IQR) | 4.5 (0–11.0) | 19.2 (2.3–30.5) | <0.0001 |
BMI (kg/m2) (mean, SD) | 25.4 (4.3) | 26.2 (3.4) | <0.0001 |
Chronic diseases | |||
Hypertension | 73.9 | 64.1 | <0.0001 |
Hypercholesterolemia | 39.4 | 34.2 | <0.0001 |
Diabetes | 5.6 | 9.9 | <0.0001 |
Ischemic disease | 11.3 | 20.7 | <0.0001 |
MMSE score (median, IQR) | 28 (27–29) | 28 (27–29) | 0.29 |
Visual or hearing impairment | 18.8 | 18.2 | 0.55 |
Dependency level | |||
Low (or fully independent) | 50.0 | 69.3 | |
Moderate (mobility restriction only) | 42.3 | 26.0 | |
High (IADL and/or ADL limitation) | 7.7 | 4.7 | <0.0001 |
Anxiolytic consumption | 17.2 | 7.6 | <0.0001 |
Antidepressant consumption | 7.0 | 2.4 | <0.0001 |
APOE ɛ4 carrier | 19.3 | 20.2 | 0.40 |
CES-D dimensions (median, IQR) | |||
Somatic affectb | 1.7 (0.6–2.9) | 1.1 (0.6–2.3) | <0.0001 |
Depressed affectb | 0.8 (0–3.2) | 0 (0–0.8) | <0.0001 |
Positive affectc | 3.0 (1–6) | 2.0 (0–4) | <0.0001 |
Interpersonal challenge | 0 (0–2) | 0 (0–1) | <0.0001 |
Total CES-D score | 9 (4–15) | 6 (2–10) | <0.0001 |
Depressive symptomatology: high (CES-D≥16) | 24.3 | 10.6 | <0.0001 |
aless than 1% missing values except for alcohol consumption (6.5%)
bstandardised to 0–12 scale
creversed so that a high score reflects low positive affect
dχ2 test for categorical variables, Student’s T-test for normally distributed continuous variables and Wilcoxon Test for skewed continuous or ordinal variables